Biotechnology revolution in korea using artificial Intelligence in korea !!!

It is concentrating on the development of new biopharmaceuticals using antibody technology, RNA, and proteins. The goal is to develop innovative biopharmaceuticals based on biotechnology to solve unmet demand for diseases for which there is no treatment. Amgen Korea announced on the 26th that from July last year to the beginning of this year, it was working with three companies with promising technologies to develop new drugs and focusing on various research and development cooperation based on biotechnology. According to the contents of the cooperation with the companies Amgen Korea has cooperated with, it has signed a research alliance with Generate Biomedicines to develop protein therapeutics using a machine learning-based platform, and cooperated with Arrakis Therapeutics to develop small molecules that degrade RNA. Arachis Therapeutics Selectively Destroys RNA... Started Developing'Small Molecular Therapeutics' On January 11, this year, Amgen and Arakis Therapeutics signed an agreement to develop new'RNA-degrading small molecule drugs'.